XML 53 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
CASH, CASH EQUIVALENTS AND INVESTMENTS (Notes)
3 Months Ended
Mar. 31, 2014
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents Disclosure [Text Block]
3.
CASH, CASH EQUIVALENTS AND INVESTMENTS:
The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method. Investments as of March 31, 2014 and December 31, 2013 consist of the following (in thousands):
 
 
Amortized
 
Unrealized
 
Aggregate Fair
Investment Classification
 
Cost
 
Gains
 
(Losses)
 
Market Value
March 31, 2014
 
 
 
 
 
 
 
 
Certificates of deposit
 
$
10,881

 
$
4

 
$
(10
)
 
$
10,875

Corporate bonds
 
218,771

 
37

 
(17
)
 
218,791

U.S. Government bonds
 
4,075

 

 

 
4,075

Convertible notes
 
300

 

 

 
300

 
 
$
234,027

 
$
41

 
$
(27
)
 
$
234,041

December 31, 2013
 
 
 
 
 
 
 
 
Certificates of deposit
 
$
11,358

 
$
2

 
$
(16
)
 
$
11,344

Corporate bonds
 
190,738

 
33

 
(48
)
 
190,723

U.S. Government bonds
 
3,074

 

 

 
3,074

Convertible notes
 
4,300

 

 

 
4,300

 
 
$
209,470

 
$
35

 
$
(64
)
 
$
209,441


On July 13, 2012, the Company entered into a joint development agreement with Plextronics, Inc. (Plextronics), a private company engaged in printed solar, lighting and other electronics related research and development. The Company invested $4.0 million in Plextronics through the purchase of a convertible promissory note. The note accrued interest at the rate of 3% per year. The note was repaid in full during the first quarter of 2014. See Fair Value Measurements below for additional information regarding the note.
On July 17, 2012, the Company invested $300,000 in a private company engaged in plasma processing equipment research and development (the Borrower) through the purchase of a convertible promissory note. The note accrues interest at the rate of 5% per year and is due and payable by August 1, 2015. The note is included in investments on the consolidated balance sheet. The Company has the option to convert the note into shares of the Borrower’s preferred stock at a specified conversion price.
All short-term investments held at March 31, 2014 will mature within one year.